The HealthCare Institute of New Jersey (HINJ) has announced new officers of its Board of Trustees and the leadership of its Steering Committee, effective July 1.
An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer (Published in the print edition of the Asbury Park Press on Friday, May
An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer Manufacturers frequently offer rebates that are passed through to consumers to reduce their
Trenton, February 14, 2022 ― “While we await the opportunity to review the actual bills that Governor Murphy proposed today, we look forward to working
An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer New Jersey’s research-based biopharmaceutical industry is constantly developing new cures and treatments that benefit
$350 billion goes to middlemen Trenton, January 11, 2022 ― An update to an important study demonstrates that pharmacy benefit managers (PBMs) and other middlemen
Steve Issenman
Senior V.P.
732-729-9621
issenman@hinj.org
